Patient-Derived hiPSC-Cardiomyocytes and Engineered Heart Tissues Reveal Distinct Functional Phenotypes in Inherited Cardiomyopathies
This study demonstrates that patient-derived hiPSC-cardiomyocytes and engineered heart tissues carrying specific HCM and DCM mutations exhibit distinct genotype-dependent molecular, structural, and functional phenotypes, including differential responses to hypertrophic stimulation and unique patterns of tissue failure, thereby validating these 3D models for investigating inherited cardiomyopathy mechanisms and drug responses.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human heart is a relentless engine, beating roughly one hundred thousand times a day to keep blood flowing through the body. When this engine is built with a flaw in its genetic blueprint, the consequences can be severe. Two of the most common inherited flaws are hypertrophic cardiomyopathy, where the heart muscle becomes abnormally thick, and dilated cardiomyopathy, where the heart becomes enlarged and weak. For decades, scientists have tried to understand exactly how these genetic errors cause the heart to fail, but studying them in living humans is difficult, and animal models often fail to capture the unique biology of human heart cells. To bridge this gap, researchers have turned to a powerful tool: human induced pluripotent stem cells. These are special cells that can be grown in a lab and coaxed into becoming beating heart muscle cells, carrying the exact genetic makeup of the patient they came from. By growing these cells in three-dimensional structures that mimic the physical stress of a real heart, scientists can watch how the disease develops and how the cells react to stress, offering a window into the mechanics of heart failure that was previously impossible to see.
In a recent study, a team of researchers used this approach to investigate the specific behaviors of heart cells from patients with these two distinct conditions. They created three types of heart cell cultures: a healthy control group, a group carrying a genetic mutation known to cause thickening of the heart muscle, and a group carrying a mutation that leads to a weakened, enlarged heart. The researchers did not just let these cells sit quietly; they subjected them to specific chemical signals that mimic the stress the heart feels during disease. One such signal is a peptide called endothelin-1, which naturally tells heart cells to grow larger and work harder. The team also tested a new compound designed to block a specific protein inside the cell that helps drive this growth response. They watched closely to see if the healthy cells and the diseased cells reacted differently to these signals, and whether the new compound could calm the reaction.
The results revealed that the genetic background of the cells dictated exactly how they responded to stress. When the healthy heart cells were exposed to the stress signal, they showed a clear, predictable pattern of growth and changes in their internal machinery. However, the cells from the patients with the thickened heart muscle and the weakened heart muscle did not follow this same script. The cells with the thickening mutation reacted differently to the stress signal than the healthy ones, showing a unique pattern of gene activity. The cells with the weakening mutation showed an even more dramatic difference. When the researchers built these cells into small, three-dimensional tissues to test their strength, the tissues made from the healthy cells held together and beat steadily for over a month. The tissues made from the thickening mutation also held together, though they beat with less force than the healthy ones. But the tissues made from the weakening mutation could not survive the physical demands of the three-dimensional environment. They began to fracture and stop beating entirely within a few weeks, unable to maintain their structure under the strain.
The study also explored what happens when these tissues are pushed to their limits. The researchers applied a chemical that mimics the body's "fight or flight" response, which normally makes the heart beat faster and stronger. In the healthy tissues, this chemical had the expected effect, increasing the speed of the beat. In the tissues from the patients with the thickening mutation, the chemical surprisingly increased the strength of the beat, suggesting these cells might be hyper-sensitive to this type of stress. However, when the researchers tried to use the new compound designed to block the growth response, the results were unexpected. Instead of simply reducing the stress response, the compound caused all the engineered heart tissues, including the healthy ones, to stop beating entirely. This suggests that the protein the compound targets is essential for the heart cells to function at all, and blocking it is too dangerous for the cells to survive.
These findings highlight that heart disease is not a single problem with a single solution. The genetic error that causes a heart to become thick leads to a different set of cellular behaviors and responses than the error that causes a heart to become weak. The fact that the tissues with the weakening mutation physically fell apart in the lab suggests that the structural integrity of the heart cells is compromised in a way that makes them unable to withstand normal physical stress. This physical fragility, combined with the unique way these cells react to stress signals, provides a clearer picture of why these diseases are so difficult to treat. The study confirms that using patient-derived cells in realistic, three-dimensional models can reveal these critical differences, showing that the path to a cure may require treatments tailored to the specific genetic flaw rather than a one-size-fits-all approach. The research underscores the complexity of the heart, where a single genetic typo can rewrite the rules of how the muscle responds to the world around it.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.